Form 8-K - Current report:
SEC Accession No. 0001169245-23-000056
Filing Date
2023-11-29
Accepted
2023-11-29 16:55:08
Documents
54
Period of Report
2023-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-20231117.htm   iXBRL 8-K 36807
2 EX-99.1 phasqmorsep2023.htm EX-99.1 31699
3 EX-99.2 phasqmoroct2023.htm EX-99.2 29641
7 phasqmoroct2023001.jpg GRAPHIC 141803
8 phasqmoroct2023002.jpg GRAPHIC 189189
9 phasqmoroct2023003.jpg GRAPHIC 174381
10 phasqmoroct2023004.jpg GRAPHIC 142466
11 phasqmoroct2023005.jpg GRAPHIC 150456
12 phasqmoroct2023006.jpg GRAPHIC 141987
13 phasqmoroct2023007.jpg GRAPHIC 143207
14 phasqmoroct2023008.jpg GRAPHIC 164424
15 phasqmoroct2023009.jpg GRAPHIC 203834
16 phasqmoroct2023010.jpg GRAPHIC 355260
17 phasqmoroct2023011.jpg GRAPHIC 344523
18 phasqmoroct2023012.jpg GRAPHIC 199811
19 phasqmoroct2023013.jpg GRAPHIC 201353
20 phasqmoroct2023014.jpg GRAPHIC 214731
21 phasqmoroct2023015.jpg GRAPHIC 80721
22 phasqmoroct2023016.jpg GRAPHIC 62361
23 phasqmoroct2023017.jpg GRAPHIC 87250
24 phasqmoroct2023018.jpg GRAPHIC 69301
25 phasqmoroct2023019.jpg GRAPHIC 69318
26 phasqmorsep2023001.jpg GRAPHIC 141829
27 phasqmorsep2023002.jpg GRAPHIC 189400
28 phasqmorsep2023003.jpg GRAPHIC 176048
29 phasqmorsep2023004.jpg GRAPHIC 142450
30 phasqmorsep2023005.jpg GRAPHIC 150431
31 phasqmorsep2023006.jpg GRAPHIC 141809
32 phasqmorsep2023007.jpg GRAPHIC 143338
33 phasqmorsep2023008.jpg GRAPHIC 164487
34 phasqmorsep2023009.jpg GRAPHIC 203723
35 phasqmorsep2023010.jpg GRAPHIC 353890
36 phasqmorsep2023011.jpg GRAPHIC 348135
37 phasqmorsep2023012.jpg GRAPHIC 199909
38 phasqmorsep2023013.jpg GRAPHIC 208788
39 phasqmorsep2023014.jpg GRAPHIC 277452
40 phasqmorsep2023015.jpg GRAPHIC 39671
41 phasqmorsep2023016.jpg GRAPHIC 51289
42 phasqmorsep2023017.jpg GRAPHIC 81921
43 phasqmorsep2023018.jpg GRAPHIC 63385
44 phasqmorsep2023019.jpg GRAPHIC 87617
45 phasqmorsep2023020.jpg GRAPHIC 69712
46 phasqmorsep2023021.jpg GRAPHIC 69680
  Complete submission text file 0001169245-23-000056.txt   9126277

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20231117.xsd EX-101.SCH 1904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20231117_lab.xml EX-101.LAB 25850
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20231117_pre.xml EX-101.PRE 13583
48 EXTRACTED XBRL INSTANCE DOCUMENT phas-20231117_htm.xml XML 2818
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 231453048
SIC: 2834 Pharmaceutical Preparations